Search Results for: ApoE4

UB 311

UB 311 is a synthetic peptide vaccine for Alzheimer’s disease being developed by United Neuroscience, a spin-off of United Biomedical. How UB 311 works A peptide is a short stretch ... Read more


CAD106 is a vaccine being developed by Novartis to potentially treat Alzheimer’s disease, or prevent it from developing, by attacking beta-amyloid plaque deposits in the brain. How CAD106 works CAD106 is designed ... Read more


CNP520 is an oral therapy that Novartis and Amgen are developing to delay the start and progression of Alzheimer’s disease. How CNP520 works The hallmark of Alzheimer’s is an accumulation of ... Read more